Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Omega Transaminase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112553285B reveals a novel omega-transaminase method for L-glufosinate-ammonium. Achieve high purity and cost reduction in agrochemical manufacturing with scalable biocatalysis.
Patent CN119530189A reveals green enzymatic route for cyclohexylamine. Offers high selectivity and reduced environmental impact for pharmaceutical intermediate supply chains.
Patent CN104894148A details a high-efficiency omega-transaminase mutant for chiral amine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN107686852B reveals a novel omega-transaminase route for moxifloxacin intermediates, offering high ee values and streamlined manufacturing for reliable pharmaceutical intermediate suppliers.
Patent CN110951706B details a high-activity R-omega-TA mutant for sitagliptin. Offers high ee value >99%, breaking technical monopolies and ensuring supply chain stability.
Patent CN110540975B reveals high-efficiency biocatalytic route for sitagliptin precursors, offering superior stereoselectivity and reduced environmental impact for pharma supply chains.
Patent CN110358804B reveals high-purity enzymatic resolution for dolutegravir synthesis, offering scalable biocatalysis solutions for reliable pharmaceutical intermediate suppliers.